The applications of nano-medicine in the breast cancer therapy
Authors:
- N A SaeedNSN A Saeed
- I H HamzahIHI H Hamzah
- S I MahmoodSMS I Mahmood
Open Access
- 1 March 2021
- conference paper
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1853 (1)
Abstract
Breast cancer (BC) is the commonest malignancy in women worldwide. Triple-negative breast cancer (TNBC) with three main-receptors which is estrogen-receptor, progesterone-receptor, and human-epidermal-growth factor receptor-2, Absent hormonal-receptor in cells of breast cancer familiar to expression an aggressive phenotypes as well as increasing the metastasis that leading to develop the resistance for chemotherapies. Different types of treatment and therapies currently can stop the spreading of BC and TNBC but with side-effects for healthy cells or tissues. Nanotechnologies present many unique efficient alternatives to designs and synthesis of small-size nanomaterial which target both active and passive and can be used to attached multi-targeting moiety by controlled cellular uptakes with a minimum amount of nanometric carriers. Which are able to carry drug, tracking-probes, and ligands, designing on same pathway, which specifically targets each cell of BC on sites. Indicating the targeted deliver-system by highly functional molecules with multi specificity, tracking, diagnosing, and treating emerge as theranostic-approach. Particularly, carbon nanomaterial such as fullerenes, nanotube and graphenes, is scientific interesting regarding the chemical functions, biological and physical characteristics. The latest scientific guide offers the possibility usage of carbon nanomaterial to be a therapeutically factors, Systematic agents to control drug releasing as well as contracting factors to diagnostic the tumor. producing new potentials to developing innovatively orders to detecting BC on the beginning and treatment period. In this review, we shed the light on traditional drugs therapy, unique therapy to providing the current nanotechnology applied for approaching metastatic BC treatment and diagnosing by using carbon nanomaterials.Keywords
This publication has 57 references indexed in Scilit:
- Classification of triple-negative breast cancers based on Immunogenomic profilingJournal of Experimental & Clinical Cancer Research, 2018
- TNM classification and the need for revision of pN3a breast cancerEuropean Journal of Cancer, 2017
- Global Cancer in Women: Burden and TrendsCancer Epidemiology, Biomarkers & Prevention, 2017
- Features of aggressive breast cancerThe Breast, 2015
- Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosisOncoImmunology, 2015
- Breast-Conserving Therapy for Triple-Negative Breast CancerJAMA Surgery, 2014
- Risk Factors for Distant Metastasis as a Primary Site of Treatment Failure in Early-Stage Breast CancerChonnam Medical Journal, 2014
- Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd EditionBreast Care, 2013
- Economic analyses of breast cancer control in low- and middle-income countries: a systematic reviewSystematic Reviews, 2013